{
    "eid": "2-s2.0-85111252287",
    "title": "Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand",
    "cover-date": "2021-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "177Lu-PSMA I&T",
        "MIRD scheme",
        "Radionuclide therapy",
        "Theranostics"
    ],
    "authors": [
        "Kotchakorn Chatachot",
        "Shuichi Shiratori",
        "Tawatchai Chaiwatanarat",
        "Kitiwat Khamwan"
    ],
    "citedby-count": 4,
    "ref-count": 38,
    "ref-list": [
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent",
        "Prostate cancer imaging with novel PET tracers",
        "Theranostic concepts: more than just a fashion trend\u2014introduction and overview",
        "Theranostics in nuclear medicine: emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology",
        "The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival",
        "Radiation exposure after177Lu-DOTATATE and177Lu-PSMA-617 therapy",
        "The rise of PSMA ligands for diagnosis and therapy of prostate cancer",
        "Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy",
        "Radiation dosimetry of68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing",
        "Radiopharmaceutical therapy in cancer: clinical advances and challenges",
        "MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry\u2014standardization of nomenclature",
        "Individualized dosimetry of kidney and bone marrow in patients undergoing177Lu-DOTA-octreotate treatment",
        "Nephrotoxicity after PRRT with177Lu-DOTA-octreotate",
        "MIRD pamphlet no 26: joint EANM/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy",
        "Bone marrow absorbed doses and correlations with hematologic response during177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases",
        "OsiriX: an open-source software for navigating in multidimensional DICOM images",
        "Methods for quantitating radioactivity, in vivo",
        "In vivo quantitation of lesion radioactivity using external counting methods",
        "The UF family of reference hybrid phantoms for computational radiation dosimetry",
        "RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry",
        "RADAR dose estimate report: a compendium of radiopharmaceutical dose estimates based on OLINDA/EXM version 20",
        "Basic anatomical and physiological data for use in radiological protection: reference values: ICRP Publication 89",
        "Lacrimal glands may represent organs at risk for radionuclide therapy of prostate cancer with [177Lu] DKFZ-PSMA-617",
        "A novel planar image-based method for bone marrow dosimetry in177Lu-DOTATATE treatment correlates with haematological toxicity",
        "Response of the normal eye to high dose radiotherapy",
        "Influence of the radiation dose to salivary glands on xerostomia in patients with head and neck carcinomas",
        "Radiation dosimetry for177Lu-PSMA I&T in metastatic castration-resistant prostate cancer: absorbed dose in normal organs and tumor lesions",
        "OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine",
        "Dosimetry for177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer",
        "Factors affecting accuracy of S values and determination of time-integrated activity in clinical Lu-177 dosimetry",
        "Dosimetry of177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes",
        "Examining absorbed doses of indigenously developed177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients at baseline and during course of peptide receptor radioligand therapy",
        "An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history",
        "A stylized computational model of the head for the reference Japanese male",
        "Photon SAF calculation based on the Chinese mathematical phantom and comparison with the ORNL phantoms",
        "NURBS-based 3-D anthropomorphic computational phantoms for radiation dosimetry applications",
        "68Ga-and177Lu-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phisanulok",
            "@id": "60011546",
            "affilname": "Buddhachinaraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011546",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University"
    ]
}